Celyad Oncology

Rue Edouard Belin 12

1435 Mont-Saint-Guibert

BE

Celyad Oncology

Foundation date

24 July 2007

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Celyad Oncology is a biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.

Latest news

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    20 hours ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    21 hours ago

  • VIB-KU Leuven study reveals FUS protein’s role in ALS and FTD

    Friday June 14th 2024